MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

Three reasons to be optimistic about bioresorbable stents

April 4, 2016 By MassDevice Leave a Comment

by Eric Distad, Senior Director, Medical Device & Diagnostics, Novella Clinical In a December 2015 blog post, I quoted a report by Technavio stating that bioresorbable coronary stents would be a key technology to watch over the next five years. Those in clinical development are either made of lactic acid polymers or use magnesium-based scaffolds, […]

Filed Under: Blog Tagged With: Novella Clinical Inc.

The combination product development 3-step: Considerations for clinical trials

December 7, 2015 By MassDevice Leave a Comment

by Eric Distad, Senior Director, Medical Device & Diagnostics, Novella Clinical The market for drug device combination products is expected to grow at a compound annual growth rate of 11.95 percent by 2019, according to a new report from Technavio. The report, which segments the market by the following product types: drug-eluting stents, prefilled syringes, […]

Filed Under: Blog Tagged With: Novella Clinical Inc.

DJO Global’s executive vice president resigns | Personnel Moves

October 3, 2011 By MassDevice staff Leave a Comment

DJo Global

Medical device maker DJO Global, Inc. announced that its executive vice president of U.S. commercial operations, Andrew Holman, will leave the company “to pursue other opportunities.”

Newly minted DJO president & CEO Mike Mogul will assume responsibility for the San Diego, Calif.-based company’s U.S. commercial activities.

Filed Under: News Well Tagged With: Biogen, Dehaier Medical Systems Ltd., DJO Global, Elekta, Novella Clinical Inc., Personnel Moves, Revolutions Medical Corp., SANUWAVE Health Inc., Stereotaxis, Stryker

Bupp steps down as Neoprobe CEO | Personnel moves

April 1, 2011 By MassDevice staff Leave a Comment

MassDevice.com Personnel Moves

Neoprobe Corp. (NYSE Amex:NEOP) is getting a new chief executive and, perhaps, a new board member.

The Dublin, Ohio-based cancer diagnostics firm announced that CEO David Bupp will be replaced by chief development officer Mark Pykett on April 15.

Filed Under: News Well Tagged With: Alphatec, Cleveland HeartLab LLC, Delcath Systems Inc., Golden Meditech Holdings Ltd., LipoScience Inc., Magnetecs Corp., Minnetronix Medical, Navidea Biopharmaceuticals, Novella Clinical Inc., Personnel Moves, Zoll Medical

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS